Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,235.50 GBX | +1.40% |
|
-1.63% | +26.07% |
Jul. 14 | August 1st Ultimatums and Other Summer Pastimes | ![]() |
Jul. 14 | Hermès, the fair price is 50 times earnings | ![]() |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.63 | 9.08 | 10.73 | 7.4 | 0.48 | |||||
Return on Total Capital | 9.24 | 11.01 | 13.11 | 9.09 | 0.58 | |||||
Return On Equity % | 27.06 | 24.99 | 31.18 | 20.13 | -7.23 | |||||
Return on Common Equity | 27.12 | 24.98 | 31.15 | 20.15 | -7.28 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 69.98 | 70.59 | 70.52 | 67.69 | 62.49 | |||||
SG&A Margin | 53.75 | 52.72 | 50.42 | 54.04 | 62.37 | |||||
EBITDA Margin % | 20.77 | 21.59 | 23.59 | 17.59 | 5.65 | |||||
EBITA Margin % | 17.73 | 18.54 | 20.52 | 14.12 | 1.1 | |||||
EBIT Margin % | 17.69 | 18.51 | 20.49 | 14.08 | 1.06 | |||||
Income From Continuing Operations Margin % | 16.04 | 14.05 | 15.9 | 9.13 | -3.05 | |||||
Net Income Margin % | 16.03 | 14.01 | 15.84 | 9.1 | -3.05 | |||||
Net Avail. For Common Margin % | 16.03 | 14.01 | 15.84 | 9.1 | -3.05 | |||||
Normalized Net Income Margin | 10.24 | 10.85 | 12.32 | 8.03 | -0.94 | |||||
Levered Free Cash Flow Margin | 18.23 | 17.22 | 16.91 | 9.25 | 13.35 | |||||
Unlevered Free Cash Flow Margin | 19.02 | 17.9 | 17.66 | 10.39 | 15.53 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.69 | 0.79 | 0.84 | 0.84 | 0.72 | |||||
Fixed Assets Turnover | 2.1 | 2.46 | 2.45 | 2.16 | 1.83 | |||||
Receivables Turnover (Average Receivables) | 18.46 | 19.42 | 19.28 | 16.67 | 15.93 | |||||
Inventory Turnover (Average Inventory) | 1.65 | 2.01 | 2.09 | 2.01 | 1.98 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.82 | 2.53 | 2.25 | 1.66 | 1.49 | |||||
Quick Ratio | 2.19 | 1.94 | 1.66 | 1.02 | 1.07 | |||||
Operating Cash Flow to Current Liabilities | 0.84 | 0.87 | 0.9 | 0.59 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 19.71 | 19.1 | 18.88 | 21.83 | 22.85 | |||||
Days Outstanding Inventory (Average Inventory) | 220.51 | 184.83 | 174.22 | 181.05 | 183.58 | |||||
Average Days Payable Outstanding | 90.71 | 67.26 | 71.59 | 65.37 | 70.63 | |||||
Cash Conversion Cycle (Average Days) | 149.52 | 136.67 | 121.51 | 137.51 | 135.8 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 87.33 | 86.64 | 96.56 | 135.7 | 209.23 | |||||
Total Debt / Total Capital | 46.62 | 46.42 | 49.12 | 57.57 | 67.66 | |||||
LT Debt/Equity | 70.96 | 70.93 | 77.97 | 109.01 | 141.91 | |||||
Long-Term Debt / Total Capital | 37.88 | 38.01 | 39.67 | 46.25 | 45.89 | |||||
Total Liabilities / Total Assets | 55.47 | 56.26 | 58.25 | 65.76 | 73.13 | |||||
EBIT / Interest Expense | 13.91 | 16.87 | 17.14 | 7.74 | 0.3 | |||||
EBITDA / Interest Expense | 22.12 | 25.74 | 25.38 | 14 | 4.49 | |||||
(EBITDA - Capex) / Interest Expense | 19.68 | 21.74 | 21.7 | 11.07 | 3.07 | |||||
Total Debt / EBITDA | 2.07 | 1.76 | 1.58 | 2.07 | 4.99 | |||||
Net Debt / EBITDA | 0.15 | 0.22 | 0.49 | 1.49 | 2.89 | |||||
Total Debt / (EBITDA - Capex) | 2.32 | 2.08 | 1.85 | 2.62 | 7.3 | |||||
Net Debt / (EBITDA - Capex) | 0.17 | 0.27 | 0.57 | 1.88 | 4.22 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -10.98 | 20.56 | 9.48 | -4.07 | -17.08 | |||||
Gross Profit, 1 Yr. Growth % | -7.53 | 21.65 | 9.37 | -7.93 | -23.44 | |||||
EBITDA, 1 Yr. Growth % | -6.78 | 25.51 | 19.67 | -28.49 | -73.37 | |||||
EBITA, 1 Yr. Growth % | -5.35 | 26.26 | 21.18 | -34.02 | -93.56 | |||||
EBIT, 1 Yr. Growth % | -5.36 | 26.33 | 21.22 | -34.07 | -93.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 209.13 | 5.59 | 23.93 | -44.92 | -127.68 | |||||
Net Income, 1 Yr. Growth % | 208.71 | 5.32 | 23.74 | -44.9 | -127.78 | |||||
Normalized Net Income, 1 Yr. Growth % | -8.39 | 27.71 | 24.35 | -37.46 | -109.7 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 211.07 | 5.39 | 29.27 | -41.49 | -128.39 | |||||
Accounts Receivable, 1 Yr. Growth % | 37.29 | -2.04 | 22.92 | 1.13 | -27.37 | |||||
Inventory, 1 Yr. Growth % | -10.74 | 5.97 | 4.93 | 13.42 | -16.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.69 | 9.47 | 10.32 | 7.01 | -10.85 | |||||
Total Assets, 1 Yr. Growth % | 6.38 | 5.57 | -0.3 | -8.57 | 1.69 | |||||
Tangible Book Value, 1 Yr. Growth % | 36.44 | 4.02 | -6.41 | -31.52 | -22.16 | |||||
Common Equity, 1 Yr. Growth % | 28.2 | 3.6 | -4.96 | -25.18 | -20.31 | |||||
Cash From Operations, 1 Yr. Growth % | 29.75 | 18.07 | 7.3 | -32.53 | -15.22 | |||||
Capital Expenditures, 1 Yr. Growth % | -14.54 | 69.86 | 9.68 | 16.18 | -22.78 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 48.59 | 14.39 | 75.25 | -47.53 | 22.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 46.92 | 13.92 | 71.84 | -43.57 | 24.01 | |||||
Dividend Per Share, 1 Yr. Growth % | 276.11 | 10.59 | 29.79 | 0 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -7.17 | 3.6 | 14.89 | 2.48 | -10.81 | |||||
Gross Profit, 2 Yr. CAGR % | -6.11 | 6.05 | 15.35 | 0.35 | -16.04 | |||||
EBITDA, 2 Yr. CAGR % | -4.43 | 8.07 | 22.56 | -7.49 | -56.36 | |||||
EBITA, 2 Yr. CAGR % | -3.47 | 9.25 | 23.7 | -10.58 | -79.38 | |||||
EBIT, 2 Yr. CAGR % | -3.48 | 9.26 | 23.75 | -10.6 | -79.75 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.29 | 80.69 | 14.39 | -17.38 | -60.96 | |||||
Net Income, 2 Yr. CAGR % | 5.23 | 80.39 | 14.16 | -17.43 | -60.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.66 | 8.15 | 26.02 | -11.81 | -75.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.52 | 81.07 | 16.72 | -13.03 | -59.24 | |||||
Accounts Receivable, 2 Yr. CAGR % | 10.78 | 16.01 | 9.73 | 11.49 | -14.3 | |||||
Inventory, 2 Yr. CAGR % | -7.02 | -2.76 | 5.45 | 9.09 | -2.61 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 89.19 | 3.19 | 9.89 | 8.65 | -2.33 | |||||
Total Assets, 2 Yr. CAGR % | 22.54 | 5.97 | 2.59 | -4.52 | -3.58 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.41 | 19.15 | -1.33 | -19.94 | -26.99 | |||||
Common Equity, 2 Yr. CAGR % | 3.43 | 15.26 | -0.77 | -15.67 | -22.78 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.9 | 23.84 | 12.56 | -14.92 | -24.37 | |||||
Capital Expenditures, 2 Yr. CAGR % | 7.91 | 20.57 | 36.49 | 12.88 | -5.29 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 27.19 | 30.07 | 10.91 | -4.1 | -20.76 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 29.84 | 29.1 | 10.91 | -1.53 | -16.35 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 103.94 | 19.8 | 13.92 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.99 | 1.28 | 5.52 | 8.19 | -4.51 | |||||
Gross Profit, 3 Yr. CAGR % | -4.74 | 2.35 | 7.15 | 7 | -8.31 | |||||
EBITDA, 3 Yr. CAGR % | -5.58 | 4.59 | 11.81 | 2.41 | -38.92 | |||||
EBITA, 3 Yr. CAGR % | -4.2 | 5.53 | 13.09 | 0.32 | -62.79 | |||||
EBIT, 3 Yr. CAGR % | -4.22 | 5.53 | 13.11 | 0.32 | -63.23 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 8.59 | 5.4 | 59.35 | -10.34 | -42.62 | |||||
Net Income, 3 Yr. CAGR % | 8.58 | 5.29 | 59.09 | -10.45 | -42.57 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.9 | 2.88 | 13.3 | -0.23 | -57.74 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.66 | 6.14 | 61.83 | -7.28 | -40.12 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.88 | 6.35 | 18.27 | 6.79 | -3.35 | |||||
Inventory, 3 Yr. CAGR % | -0.79 | -2.88 | -0.26 | 8.04 | -0.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 51.87 | 57.63 | 5.51 | 8.92 | 1.72 | |||||
Total Assets, 3 Yr. CAGR % | 16.36 | 16.6 | 3.84 | -1.27 | -2.5 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.08 | 3.62 | 9.93 | -12.64 | -20.69 | |||||
Common Equity, 3 Yr. CAGR % | 3.1 | 3.5 | 8.08 | -9.69 | -17.25 | |||||
Cash From Operations, 3 Yr. CAGR % | -4.47 | 19.33 | 18.06 | -5.1 | -15.02 | |||||
Capital Expenditures, 3 Yr. CAGR % | 8.23 | 25.59 | 16.82 | 29.35 | -0.54 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -5.36 | 22.58 | 22.07 | -13.58 | 3.24 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -4.05 | 24.12 | 21.64 | -11.46 | 6.34 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0.96 | 3.41 | 75.42 | 12.8 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -1.4 | 0.43 | 2.51 | 1.76 | -1.34 | |||||
Gross Profit, 5 Yr. CAGR % | -1.43 | 0.63 | 2.83 | 1.54 | -2.81 | |||||
EBITDA, 5 Yr. CAGR % | -1.71 | 0.98 | 4.77 | -0.42 | -23.26 | |||||
EBITA, 5 Yr. CAGR % | -0.16 | 2.66 | 6.09 | -1.24 | -42.75 | |||||
EBIT, 5 Yr. CAGR % | 0.57 | 3 | 6.09 | -1.24 | -43.16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 3.62 | 6.65 | 10.88 | -4.38 | -9.21 | |||||
Net Income, 5 Yr. CAGR % | 3.95 | 6.67 | 10.79 | -4.47 | -9.23 | |||||
Normalized Net Income, 5 Yr. CAGR % | -0.69 | 1.58 | 5.08 | -3.27 | -38.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5.96 | 8.52 | 13.05 | -1.99 | -6.78 | |||||
Accounts Receivable, 5 Yr. CAGR % | -5.79 | -5.57 | 8.63 | 8.38 | 3.97 | |||||
Inventory, 5 Yr. CAGR % | -3.75 | -3.36 | 1.65 | 1.74 | -1.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.85 | 24.64 | 33.42 | 35.83 | 2.3 | |||||
Total Assets, 5 Yr. CAGR % | 8.64 | 8.9 | 10.64 | 7.64 | 0.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.82 | -2.04 | 0.71 | -6.54 | -6.67 | |||||
Common Equity, 5 Yr. CAGR % | -0.11 | -0.96 | 1.54 | -4.65 | -5.52 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.53 | 4.51 | 2.03 | 4.23 | -1.2 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.44 | 11.7 | 18.79 | 20.34 | 7.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 20.95 | 5.45 | 0.75 | 0.77 | 2.7 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 21.85 | 6.24 | 1.59 | 3.11 | 4.72 | |||||
Dividend Per Share, 5 Yr. CAGR % | 2.81 | 3.86 | 8.11 | 7.5 | - |
- Stock Market
- Equities
- BRBY Stock
- Financials Burberry Group plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions